Summary of the II international consensus symposium on combined antiviral therapy and implications for future therapies

被引：3

作者：

deJong, MD

Boucher, CAB

Cooper, DA

Galasso, GJ

Gazzard, B

Lange, JMA

Montaner, JS

Richman, DD

Thomas, HC

机构：

[1] UNIV UTRECHT, EIJKMAN WINKLER INST, DEPT VIROL, UTRECHT, NETHERLANDS

[2] UNIV NEW S WALES, HIV MED UNIT, ST VINCENTS HOSP, SYDNEY, NSW, AUSTRALIA

[3] NATL FDN BIOMED RES, BETHESDA, MD USA

[4] CHELSEA & WESTMINSTER HOSP, DEPT HIV GUM, LONDON, ENGLAND

[5] UNIV AMSTERDAM, ACAD MED CTR, NATL AIDS THERAPY EVALUAT CTR, DEPT INFECT DIS TROP MED & AIDS, NL-1105 AZ AMSTERDAM, NETHERLANDS

[6] UNIV BRITISH COLUMBIA, ST PAULS HOSP, BRITISH COLUMBIA CTR EXCELLENCE HIV AIDS, VANCOUVER, BC V5Z 1M9, CANADA

[7] UNIV CALIF SAN DIEGO, DEPT PATHOL, LA JOLLA, CA 92093 USA

[8] UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA

[9] UNIV CALIF SAN DIEGO, SAN DIEGO VET AFFAIRS MED CTR, LA JOLLA, CA 92093 USA

[10] UNIV LONDON, ST MARYS HOSP, DEPT MED, LONDON, ENGLAND

来源：

ANTIVIRAL RESEARCH | 1997年 / 35卷 / 02期

关键词：

D O I：

10.1016/S0166-3542(97)00020-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：65 / 82

页数：18

共 130 条

[11] Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease [J].

Boivin, G ;

Chou, SW ;

Quirk, MR ;

Erice, A ;

Jordan, MC .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03) :523-528

[12] TREATMENT OF CHRONIC HEPATITIS-B WITH RECOMBINANT INTERFERON-ALPHA VERSUS RECOMBINANT INTERFERON-ALPHA PLUS LEVAMISOLE [J].

BOSCH, O ;

MORALEDA, G ;

CASTILLO, I ;

CARRENO, V .

JOURNAL OF HEPATOLOGY, 1993, 19 (03) :437-441

[13] KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS INFECTS ENDOTHELIAL AND SPINDLE CELLS [J].

BOSHOFF, C ;

SCHULZ, TF ;

KENNEDY, MM ;

GRAHAM, AK ;

FISHER, C ;

THOMAS, A ;

MCGEE, JO ;

WEISS, RA ;

OLEARY, JJ .

NATURE MEDICINE, 1995, 1 (12) :1274-1278

[14]

BOSHOFF C, 1995, LANCET, V345, P1043

[15] COMBINED ALPHA-INTERFERON AND RIBAVIRIN TREATMENT IN CHRONIC HEPATITIS-C - A PILOT-STUDY [J].

BRACONIER, JH ;

PAULSEN, O ;

ENGMAN, K ;

WIDELL, A .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1995, 27 (04) :325-329

[16]

Brillanti S, 1995, J HEPATOL, V23, P13

[17] PILOT-STUDY OF COMBINATION THERAPY WITH RIBAVIRIN PLUS INTERFERON-ALFA FOR INTERFERON ALFA-RESISTANT CHRONIC HEPATITIS-C [J].

BRILLANTI, S ;

GARSON, J ;

FOLI, M ;

WHITBY, K ;

DEAVILLE, R ;

MASCI, C ;

MIGLIOLI, M ;

BARBARA, L .

GASTROENTEROLOGY, 1994, 107 (03) :812-817

[18] WHICH PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION WILL RESPOND TO ALPHA-INTERFERON THERAPY - A STATISTICAL-ANALYSIS OF PREDICTIVE FACTORS [J].

BROOK, MG ;

KARAYIANNIS, P ;

THOMAS, HC .

HEPATOLOGY, 1989, 10 (05) :761-763

[19] RESPIRATORY SYNCYTIAL VIRUS IN EARLY INFANCY - CIRCULATING ANTIBODY AND SEVERITY OF INFECTION [J].

BRUHN, FW ;

YEAGER, AS .

AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1977, 131 (02) :145-148

[20]

Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P612

← 1 2 3 4 5 6 7 8 9 10 →